Axonics
United StatesWho owns Axonics?
Axonics is an American MedTech company, now owned by Boston Scientific, which acquired it in 2024 from Edmond de Rothschild Private Equity (France).
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Key facts
- ·Fully exited in 2024 to Boston Scientific.
- ·Average hold across 2 realized cycles: 8 years.
Ownership history
2 ownership periods · co-invest detected
Andera Partners took Axonics public via IPO in 2019 after 5 years.
Edmond de Rothschild Private Equity (France) sold Axonics to Boston Scientific in 2024 after 10 years.
More from Edmond de Rothschild Investment Partners BioDiscovery 4
Other portfolio companies in the same fund.
Finland
FranceMore Edmond de Rothschild Private Equity (France) portfolio companies
From the same investor, across funds.
Germany
Ireland
More PE-backed in MedTech
Comparable medtech deals from other GPs.
Questions
Who owns Axonics?
Axonics is now owned by Boston Scientific, which acquired it in 2024 from Edmond de Rothschild Private Equity (France).
When did Boston Scientific acquire Axonics?
Boston Scientific acquired Axonics in 2024, buying from Edmond de Rothschild Private Equity (France).
Who did Axonics sell to?
Edmond de Rothschild Private Equity (France) sold Axonics to Boston Scientific in 2024 (Trade Sale). Andera Partners sold Axonics to Public market in 2019 (IPO).
Who has owned Axonics over time?
Axonics has been through 2 private-equity ownership periods: Andera Partners · via BioDiscovery 4 · 2014–2019 · sold to Public market · (IPO); Edmond de Rothschild Private Equity (France) · via Edmond de Rothschild Investment Partners BioDiscovery 4 · 2014–2024 · sold to Boston Scientific · (Trade Sale).